Literature DB >> 33796166

Unexpected low burden of coronavirus disease 2019 (COVID-19) in sub-Saharan Africa region despite disastrous predictions: reasons and perspectives.

Daryl Nzokou Tcheutchoua1, Aurel Tiakouang Tankeu2,3, Dominic Leandry Wouna Angong4, Batakeh Ba Agoons4, Nathan Yves Yanwou Nguemnang1, Hugues Clotaire Nana Djeunga3, Joseph Kamgno3,4.   

Abstract

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the development of a highly contagious disease called coronavirus disease (COVID-19). Ten months after the onset of the pandemic, America and Europe remain the most affected regions. Initially, experts predicted that Africa, the poorest continent with the most vulnerable population and health system, would be greatly affected by the ongoing outbreak. However, 240days after the first confirmed case, Africa is among the least affected region, with lower than expected incident cases and mortality. In this review, we discuss possible explanations and reasons for this unexpected low burden of COVID-19 in Africa. We focus on the characteristics of the virus, specificities of the sub-Saharan African population and local environment. Copyright: Daryl Nzokou Tcheutchoua et al.

Entities:  

Keywords:  COVID-19; Severe acute respiratory syndrome coronavirus-2; burden; explanations; reasons; sub-Saharan Africa

Mesh:

Year:  2020        PMID: 33796166      PMCID: PMC7992902          DOI: 10.11604/pamj.2020.37.352.25254

Source DB:  PubMed          Journal:  Pan Afr Med J


  41 in total

1.  COVID-19 in Africa.

Authors:  Charlotte Payne
Journal:  Nat Hum Behav       Date:  2020-05

2.  Effective transmission across the globe: the role of climate in COVID-19 mitigation strategies.

Authors:  Kathleen M O'Reilly; Megan Auzenbergs; Yalda Jafari; Yang Liu; Stefan Flasche; Rachel Lowe
Journal:  Lancet Planet Health       Date:  2020-05-06

3.  Association between ambient temperature and COVID-19 infection in 122 cities from China.

Authors:  Jingui Xie; Yongjian Zhu
Journal:  Sci Total Environ       Date:  2020-03-30       Impact factor: 7.963

4.  The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Authors:  Leon Caly; Julian D Druce; Mike G Catton; David A Jans; Kylie M Wagstaff
Journal:  Antiviral Res       Date:  2020-04-03       Impact factor: 5.970

5.  Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.

Authors:  Juliana Cepelowicz Rajter; Michael S Sherman; Naaz Fatteh; Fabio Vogel; Jamie Sacks; Jean-Jacques Rajter
Journal:  Chest       Date:  2020-10-13       Impact factor: 9.410

Review 6.  Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.

Authors:  Yang Yang; Md Sahidul Islam; Jin Wang; Yuan Li; Xin Chen
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

7.  Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.

Authors:  Nathan Kapata; Chikwe Ihekweazu; Francine Ntoumi; Tajudeen Raji; Pascalina Chanda-Kapata; Peter Mwaba; Victor Mukonka; Matthew Bates; John Tembo; Victor Corman; Sayoki Mfinanga; Danny Asogun; Linzy Elton; Liã Bárbara Arruda; Margaret J Thomason; Leonard Mboera; Alexei Yavlinsky; Najmul Haider; David Simons; Lara Hollmann; Swaib A Lule; Francisco Veas; Muzamil Mahdi Abdel Hamid; Osman Dar; Sarah Edwards; Francesco Vairo; Timothy D McHugh; Christian Drosten; Richard Kock; Giuseppe Ippolito; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2020-02-28       Impact factor: 3.623

8.  The Late Arrival of Coronavirus Disease 2019 (COVID-19) in Africa: Mitigating Pan-continental Spread.

Authors:  Jean Nachega; Moussa Seydi; Alimuddin Zumla
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

Review 9.  Human Mobility and the Global Spread of Infectious Diseases: A Focus on Air Travel.

Authors:  Aidan Findlater; Isaac I Bogoch
Journal:  Trends Parasitol       Date:  2018-07-23

10.  Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-27       Impact factor: 17.586

View more
  1 in total

1.  Overlapping of Pulmonary Fibrosis of Postacute COVID-19 Syndrome and Tuberculosis in the Helminth Coinfection Setting in Sub-Saharan Africa.

Authors:  Luis Fonte; Armando Acosta; María E Sarmiento; Mohd Nor Norazmi; María Ginori; Yaxsier de Armas; Enrique J Calderón
Journal:  Trop Med Infect Dis       Date:  2022-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.